GlassScriptPhysician profile
Christopher De Haydu
NPI 1851738793
$7,742.73
in general payments reported to CMS, 2019-2025
15 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.86 · 2021: $192 · 2022: $172 · 2023: $6,531 · 2024: $386 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,228 · Food and Beverage: $993 · Education: $81.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,227.54 |
| Food and Beverage | $993.43 |
| Education | $81.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $6,285.36 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $412.46 | 2021-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coloplast Corp | $240.94 | 2025 | |
| Astellas Pharma US INC | $223.97 | 2023-2024 | Veozah |
| Pfizer INC. | $178.16 | 2022-2025 | |
| Daiichi Sankyo INC. | $75.19 | 2022-2024 | Injectafer |
| Coopersurgical, INC. | $69.45 | 2025 | Ally II Ups |
| Tesaro, INC. | $61.03 | 2019 | |
| Channel Medsystems, INC. | $56.09 | 2023 | |
| Abbvie INC. | $42.67 | 2021 | |
| Millicent US INC | $26.70 | 2024 | |
| Arthrex, INC. | $24.00 | 2022 | |
| Smith+Nephew, INC. | $18.14 | 2024 | Stravix Pl, Grafix Pl |
| Astrazeneca Pharmaceuticals LP | $14.83 | 2019 | |
| Mimedx Group, INC. | $13.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher De Haydu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.